Ruth Danoff was 50 when she was diagnosed with Attention-Deficit/ Hyperactivity Disorder or ADHD. At 63, she can look back ...

Dr Ray O’Connor takes a look at some of the most recent clinical studies on Attention-deficit hyperactivity disorder (ADHD) ...

Cingulate (CING) released Phase 3 safety data for its lead asset CTx-1301 for the treatment of Attention Deficit Hyperactivity Disorder, ADHD.

Researchers sought to assess whether methylphenidate improves sleep disturbances in children with ADHD and whether dysregulation profile can affect this improvement.

Your gut health may be more closely related to mental health conditions, including ADHD, than you think. Learn the connection ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, dosage and administration, and place in therapy of atomoxetine in the treatment of attention-deficit ...

Results Have Been Submitted Ahead of In-Person Meeting with FDA Set for April 2CTx-1301 is the First, True, Once-Daily Stimulant Medication to ...

The following is a summary of "Acetaminophen in Pregnancy and Attention-Deficit and Hyperactivity Disorder and Autism ...

ADHD in women is still under-recognized and underdiagnosed. Women with ADHD also face unique challenges, including stigma and ...

Prescriptions for ADHD drugs jump 18% year-on-year, figures show - Increasing awareness of ADHD on TikTok and Instagram could ...

Charlie Health explores how groups can help people navigate ADHD symptoms, build coping strategies, and foster a sense of ...